Figure 9.

Heart rate in triadimefon treated embryos at 120 hpf. Heart rates in beats per minute (bpm) were counted in control (n = 20) and experimental embryos (18 and 16 embryos examined from the 2 and 4μg/mL triadimefon groups respectively). Embryos exposed to 2 μg/mL triadimefon presented a minor inhibition in heart rate (150.5 bpm). On the other hand, heart rate was drastically inhibited in 4 μg/mL triadimefon treated embryos (82.0 bpm), compared to 0.1% DMSO controls (156.8 bpm). Asterisks denote significant difference between triadimefon treatments and controls (*** p < 0.001). FON, triadimefon. Error bars indicate standard deviations.